Literature DB >> 19796884

Complications following linear accelerator based stereotactic radiation for cerebral arteriovenous malformations.

Jane Skjøth-Rasmussen1, Henrik Roed, Lars Ohlhues, Bo Jespersen, Marianne Juhler.   

Abstract

PURPOSE: Primarily, gamma knife centers are predominant in publishing results on arteriovenous malformations (AVM) treatments including reports on risk profile. However, many patients are treated using a linear accelerator-most of these at smaller centers. Because this setting is different from a large gamma knife center, the risk profile at Linac departments could be different from the reported experience. Prescribed radiation doses are dependent on AVM volume. This study details results from a medium sized Linac department center focusing on risk profiles. METHOD AND MATERIALS: A database was searched for all patients with AVMs. We included 50 consecutive patients with a minimum of 24 months follow-up (24-51 months).
RESULTS: AVM occlusion was verified in 78% of patients (39/50). AVM occlusion without new deficits (excellent outcome) was obtained in 44%. Good or fair outcome (AVM occlusion with mild or moderate new deficits) was seen in 30%. Severe complications after AVM occlusion occurred in 4% with a median interval of 15 months after treatment (range, 1-26 months).
CONCLUSIONS: We applied an AVM grading score developed at the Mayo Clinic to predict probable outcome after radiosurgery in a large patient population treated with Gamma knife. A cutoff above and below a score of 1.5 could not discriminate between the likelihood of having an excellent outcome (approximately 45%). The chance of having an excellent or good outcome was slightly higher in patients with an AVM score below 1.5 (64% vs. 57%). Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19796884     DOI: 10.1016/j.ijrobp.2009.05.048

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  Multimodality treatment approach in children with cerebral arteriovenous malformation--a survey in the Danish population.

Authors:  Jane Skjøth-Rasmussen; Tina Obbekjær; Peter Birkeland; John Hauerberg; Marianne Juhler
Journal:  Childs Nerv Syst       Date:  2011-12-08       Impact factor: 1.475

Review 2.  Modern robot-assisted radiosurgery of cerebral angiomas-own experiences, system comparisons, and comprehensive literature overview.

Authors:  Thomas Feutren; Andres Huertas; Julia Salleron; René Anxionnat; Serge Bracard; Olivier Klein; Didier Peiffert; Valérie Bernier-Chastagner
Journal:  Neurosurg Rev       Date:  2017-11-05       Impact factor: 3.042

3.  Diagnosis and treatment of vascular malformations of the brain.

Authors:  Bradley A Gross; Rose Du
Journal:  Curr Treat Options Neurol       Date:  2014-01       Impact factor: 3.598

4.  Hemodynamic changes in patients with arteriovenous malformations assessed using high-resolution 3D radial phase-contrast MR angiography.

Authors:  W Chang; M W Loecher; Y Wu; D B Niemann; B Ciske; B Aagaard-Kienitz; S Kecskemeti; K M Johnson; O Wieben; C Mistretta; P Turski
Journal:  AJNR Am J Neuroradiol       Date:  2012-04-12       Impact factor: 3.825

5.  Late clinical and radiological complications of stereotactical radiosurgery of arteriovenous malformations of the brain.

Authors:  Vera Parkhutik; Aida Lago; Fernando Aparici; Juan Francisco Vazquez; Jose Ignacio Tembl; Lourdes Guillen; Esperanza Mainar; Victor Vazquez
Journal:  Neuroradiology       Date:  2012-11-27       Impact factor: 2.804

6.  Intensity-modulated stereotactic radiosurgery for arteriovenous malformations: guidance for treatment planning.

Authors:  Marcus Sonier; Ermias Gete; Chris Herbert; Michael McKenzie; James Murphy; Vitali Moiseenko
Journal:  Radiat Oncol       Date:  2014-03-10       Impact factor: 3.481

Review 7.  Long-term control of large pontine arteriovenous malformation using gamma knife therapy: a review with illustrative case.

Authors:  Martin M Mortazavi; Daxa Patel; Christoph J Griessenauer; R Shane Tubbs; Winfield S Fisher
Journal:  Brain Behav       Date:  2013-06-12       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.